Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation

NCT02002923 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

160

Enrollment

NETWORK

Sponsor class

Conditions

Paroxysmal Atrial Fibrillation
Persistent Atrial Fibrillation

Interventions

PROCEDURE: Pulmonary vein isolation
DRUG: Botulinum Toxin

Sponsor

Meshalkin Research Institute of Pathology of Circulation